DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION AGREEMENTDevelopment, Manufacturing And • September 6th, 2017 • Sol-Gel Technologies Ltd. • Pharmaceutical preparations
Contract Type FiledSeptember 6th, 2017 Company IndustryThis Development, Manufacturing and Commercialization Agreement (the “Agreement”) is entered into as of April 27, 2015 (the “Effective Date”) between Perrigo UK Finco Limited Partnership, a United Kingdom limited partnership (“Perrigo UK”), and Sol-Gel Technologies Ltd., a limited liability company incorporated in Israel (“Sol-Gel”). Perrigo UK and Sol-Gel are sometimes each referred to as a “Party” and collectively as the “Parties.”
AMENDMENT TO DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION AGREEMENTDevelopment, Manufacturing and Commercialization Agreement • September 6th, 2017 • Sol-Gel Technologies Ltd. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 6th, 2017 Company Industry JurisdictionThis is an Amendment to the Development, Manufacturing and Commercialization Agreement (the “Agreement”) dated April 27, 2015, between Perrigo UK Finco Limited Partnership, a United Kingdom limited partnership (“Perrigo UK”), and Sol-Gel Technologies Ltd., a limited liability company incorporated in Israel (“Sol-Gel”). Perrigo UK and Sol-Gel may hereafter be referred to collectively as the “Parties” and individually as a “Party.” The Effective Date of this Amendment is October 26, 2015 (the “Effective Date”).